Helsinki-based health technology firm CurifyLabs has closed a $14 million Series A round to grow its automated system for producing personalized medications. The round was co-led by Sandwater and HealthCap, with Tesi and existing backers including Lifeline Ventures joining, alongside participation from U.S. customers and employees. The company, which also operates out of Jacksonville, Florida,…